Lifecore Biomedical (LFCR) has signed an agreement with a global pharmaceutical company to provide technical transfer support and commercial manufacturing for an injectable neurology suspension product, the company said Monday.
The company will provide tech transfer services for the currently marketed product as part of its late-stage pipeline expansion efforts.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.